Skip to main content
PODD
NASDAQ Industrial Applications And Services

Insulet Tops Q3 Guidance, Lifts FY26 Outlook, and Authorizes $1B Buyback

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$155.77
Mkt Cap
$10.74B
52W Low
$126.4
52W High
$354.88
52W Position info
23% above low
Off High info
56% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

PODD sits 23% above its 52-week low of $126.4.

Summary

Insulet beat the high end of its Q3 revenue guidance with $842.0M (+19.2%) and a 22.5% operating margin, raised FY26 growth and margin guidance, and authorized a new $1B share repurchase with ~$400M planned for Q4 2026.


Key Events · Earnings and Guidance · PODD

  • Q3 Revenue Beats High End of Guidance

    Revenue of $842.0M rose 19.2%, or 19.6% in constant currency, slightly above the 17.5%-19.5% constant-currency guidance range. Total Omnipod revenue of $836.6M grew 19.7%, with International up 31.7%.

  • Margins Expand Sharply

    Operating income of $189.8M was 22.5% of revenue, up 590 bps year over year; adjusted operating income of $185.2M was 22.0%, up 490 bps. Adjusted EPS of $1.99 rose 59.9% from $1.24.

  • FY26 Guidance Raised

    Total Omnipod constant-currency growth guidance moves to 21.5%-22.5% from 21%-23%, International to 32%-33% from 30%-32%, and adjusted operating margin expansion to ~150 bps YoY from ~100 bps.

  • New $1B Buyback Authorized

    The board authorized up to $1 billion of repurchases through December 31, 2028, with approximately $400 million planned for Q4 2026 funded from existing cash. This is in addition to, and does not impact, prior authorizations.


Analysis · PODD · Industrial Applications And Services

The headline beat came with real profit leverage, not discounting: revenue rose 19.2% to $842.0M, above the top of the company's own 17.5%-19.5% constant-currency range, while operating margin expanded 590 bps to 22.5%. Management then raised full-year constant-currency growth to 21%-22.5% and now expects ~150 bps of adjusted operating margin expansion instead of ~100 bps. Alongside that, the board authorized a new $1B repurchase program through December 2028, with roughly $400M earmarked for Q4 2026 from existing cash — a large step up from the prior $475M authorization and a direct signal that management sees the shares as undervalued relative to the Omnipod franchise. The offsetting detail is cash: $584.4M on the balance sheet at September 30, so the Q4 buyback alone would consume most of it, leaving the $750M revolver as the liquidity backstop.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PODD was trading at $155.77 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $10.7B. The 52-week trading range was $126.40 to $354.88. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PODD - Latest Insights

PODD
Nov 04, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $165.02
Real-time Price: $140.16 info
Change: -$24.86 (-15%) info
Market Cap: $9.711B info
PODD
Nov 04, 2026, 2:21 PM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $162.27
Real-time Price: $140.16 info
Change: -$22.10 (-14%) info
Market Cap: $9.711B info
PODD
Nov 04, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $155.77
Real-time Price: $140.16 info
Change: -$15.61 (-10%) info
Market Cap: $9.711B info
PODD
Aug 05, 2026, 8:01 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $144.52
Real-time Price: $140.16 info
Change: -$4.36 (-3%) info
Market Cap: $9.711B info
PODD
Aug 05, 2026, 7:04 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $147.60
Real-time Price: $140.16 info
Change: -$7.44 (-5%) info
Market Cap: $9.711B info